Somatically acquired mutations in primary myelofibrosis: A case report and meta‑analysis
- 7 January 2021
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 21 (3), 1
- https://doi.org/10.3892/etm.2021.9625
Abstract
Familial myeloproliferative disease (MPD) cases account for 7.6% of the global MPD cases. The present study reported 2 cases of primary myelofibrosis (PMF). The patients were two sisters; the older sister succumbed to the disease at the age of 37, whereas the younger sister maintained a stable disease status and gave birth to a son through in vitro fertilization. Genetic analysis of bone marrow DNA samples showed that both sisters carried a Janus kinase 2 (JAK2) V617F mutation, and the older sister also had a trisomy 8 chromosomal abnormality (47, XX, +8). A systematic literature search was also performed using PubMed, CNKI and Wanfang databases, to determine the association between JAK2 and PMF. Following comprehensive screening of the published literature, 19 studies were found to be eligible for the current meta‑analysis. The results showed that JAK2 V617F was a risk factor of PMF, and no sex dimorphism was observed in JAK2 V617F mutation prevalence amongst all PMF cases. In addition, there was a lack of association between the JAK2 V617F mutation and PMF‑related mortality.Keywords
This publication has 52 references indexed in Scilit:
- Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complicationsBlood Cells, Molecules, and Diseases, 2012
- Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and MyelofibrosisJournal of Hematology & Oncology, 2012
- EZH2 mutational status predicts poor survival in myelofibrosisBlood, 2011
- Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypesHaematologica, 2011
- Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosisBMC Gastroenterology, 2010
- Identification of a novel TEL–Lyn fusion gene in primary myelofibrosisLeukemia, 2009
- Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential ThrombocythemiaTransplantation and Cellular Therapy, 2007
- The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of ageBest Practice & Research Clinical Haematology, 2007
- Myelofibrosis with myeloid metaplasia in young indidviduals: disease characteristics, prognostic factors and identification of risk groupsBritish Journal of Haematology, 1998
- Dry tap bone marrow aspiration: Clinical significanceAmerican Journal of Hematology, 1990